Description
Azafab 100mg Injection contains Azacitidine, a hypomethylating agent used in the treatment of myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). It works by inhibiting DNA methyltransferase, which leads to hypomethylation of DNA and subsequent re-expression of tumor suppressor genes. This process can help to restore normal blood cell production and control the growth of cancerous cells.
Azafab 100mg Injection is administered by a healthcare professional via subcutaneous or intravenous injection. The dosage and duration of treatment will depend on the specific condition being treated, the patient’s response, and other individual factors. Common side effects may include fatigue, nausea, vomiting, diarrhea, fever, and low blood cell counts (anemia, neutropenia, thrombocytopenia). It is crucial to inform your doctor about any pre-existing medical conditions, especially kidney or liver problems, and any other medications you are taking.
Store Azafab 100mg Injection at room temperature, protected from light. Do not freeze. It is essential to follow your doctor’s instructions carefully regarding the administration and handling of this medication.
